Document:

<PAGE>

                                                                   EXHIBIT 10.20

                               PROMISSORY NOTE

$71,500                                                       San Francisco, CA

                                                             September 22, 1999

          FOR VALUE RECEIVED, CHAITAN KHOSLA promises to pay Kosan
Biosciences Incorporated (the "Company"), or order, the principal sum of
seventy-one thousand, five hundred ($71,500), together with interest on the
unpaid principal hereof from the date hereof at the rate of five and 89/100
percent (5.89%) per annum, compounded semiannually.

          Principal and interest shall be due and payable on September 22,
2002. Should the undersigned fail to make full payment of principal or
interest for a period of 10 days or more after the due date thereof, the
whole unpaid balance on this Note of principal and interest shall become
immediately due at the option of the holder of this Note. Payment of
principal and interest shall be made in lawful money of the United States of
America.

          The undersigned may at any time prepay all or any portion of the
principal or interest owing hereunder.

          This Note is subject to the terms of the Option, dated as of
October 23, 1998. This Note is secured in part by a pledge of the Company's
Common Stock under the terms of a Security Agreement of even date herewith
and is subject to all the provisions thereof.

          The holder of this Note shall have full recourse against the
undersigned, and shall not be required to proceed against the collateral
securing this Note in the event of default.

          In the event the undersigned shall cease to be an employee or
consultant of the Company for any reason, this Note shall, at the option of
the Company, be accelerated, and the whole unpaid balance on this Note of
principal and accrued interest shall be immediately due and payable.

          Should any action be instituted for the collection of this Note,
the reasonable costs and attorneys' fees therein of the holder shall be paid
by the undersigned.

                                       /s/ Chaitan Khosla
                                       -----------------------------------
                                       Signature

                                           CHAITAN KHOSLA
                                       -----------------------------------
                                       Print Name<PAGE>

                                                                 EXHIBIT 10.28

                         KOSAN BIOSCIENCES INCORPORATED

                               ---------------

                   SERIES C PREFERRED STOCK PURCHASE AGREEMENT

        This Series C Preferred Stock Purchase Agreement (the "Agreement") is
made as of March 30, 2000 among Kosan Biosciences Incorporated, a California
corporation (the "Company"), with principal executive offices at 3832 Bay Center
Place, Hayward, California 94545, and the persons and entities listed on the
Schedule of Purchasers attached hereto as EXHIBIT A (the "Purchasers").

                                  SECTION  1.

                  AUTHORIZATION AND SALE OF SERIES C PREFERRED STOCK

          1.1  AUTHORIZATION OF SERIES C PREFERRED STOCK. Prior to the
Closing (as defined in Section 2 below), the Company will have duly adopted
and filed with the California Secretary of State its Amended and Restated
Articles of Incorporation (the "Articles") in the form attached hereto as
EXHIBIT B, authorizing the issuance of shares of Series C Preferred Stock
(the "Series C Preferred") having the rights, privileges, and preferences set
forth therein, and will have authorized the issuance pursuant to this
Agreement of up to 1,050,000 shares of Series C Preferred (the "Shares"). For
purposes hereof, the "Conversion Stock" means the shares of the Company's
Common Stock issuable or issued upon conversion of the Shares issued and sold
pursuant to this Agreement.

          1.2  SALE OF SERIES C PREFERRED STOCK. Subject to the terms and
conditions of this Agreement, the Company will severally issue and sell to
each Purchaser at the Closing, and each Purchaser will severally buy from the
Company, that number of shares of Series C Preferred specified opposite such
Purchaser's name in the Schedule of Purchasers attached hereto as EXHIBIT A
for a purchase price of $31.00 per share. The Company's agreement with each
Purchaser is a separate agreement, and the sale of the Series C Preferred to
each Purchaser is a separate sale.

                                   SECTION  2

                            CLOSING DATES; DELIVERY

          2.1  CLOSING DATES. The closing of the purchase and sale of the
Series C Preferred hereunder shall take place at the offices of Wilson
Sonsini Goodrich & Rosati, 650 Page Mill Road, Palo Alto, California at 10:00
a.m., local time, on March 30, 2000 (the "Closing"), or at such other time
and place upon which the Company and the Purchasers shall agree. The date of
the Closing is hereinafter referred to as the "Closing Date."

          2.2  DELIVERY. At the Closing, the Company will deliver to each
Purchaser a certificate or certificates, registered in such Purchaser's name
set forth on the Schedule of

<PAGE>

Purchasers, representing the number of shares of Series C Preferred
designated in the Schedule of Purchasers to be purchased by such Purchaser,
against delivery to the Company by such Purchaser of a check payable to the
Company or a wire transfer per the Company's instructions in the amount of
the purchase price therefor, as indicated in the Schedule of Purchasers.

                                   SECTION  3

                   REPRESENTATIONS AND WARRANTIES OF THE COMPANY

        Except as set forth in the Schedule of Exceptions attached hereto as
EXHIBIT C, the Company represents and warrants to the Purchasers as follows:

          3.1  ORGANIZATION AND STANDING. The Company is a corporation duly
organized and validly existing under, and by virtue of, the laws of the State
of California and is in good standing under such laws. The Company has
requisite corporate power and authority to own and operate its properties and
assets, and to carry on its business as presently conducted and as presently
contemplated to be conducted. The Company is not currently qualified to do
business as a foreign corporation in any jurisdiction, and the failure to be
so qualified will not have a material adverse affect on the Company's
business as now conducted. The Company has made available to the Purchasers
copies of the Articles and the Company's Bylaws, as currently in effect.

          3.2  CORPORATE POWER. The Company has and will have at the Closing
Date all requisite legal and corporate power and authority to execute and
deliver this Agreement, the Third Amended and Restated Registration Rights
Agreement in the form attached hereto as EXHIBIT D (the "Registration Rights
Agreement"), the Third Amended and Restated Voting Agreement in the form
attached hereto as EXHIBIT E (the "Voting Agreement"), to sell and issue the
Shares hereunder, to issue the Conversion Stock and to carry out and perform
its obligations under the terms of this Agreement, the Registration Rights
Agreement and the Voting Agreement.

          3.3  SUBSIDIARIES. The Company has no subsidiaries or affiliated
companies and does not otherwise own or control, directly or indirectly, any
equity interest in any corporation, association or business entity.

          3.4  CAPITALIZATION. Immediately prior to the Closing, the
authorized capital stock of the Company will consist of 12,000,000 shares of
Common Stock and 4,348,182 shares of Preferred Stock, 1,480,000 shares of
which are designated "Series A Preferred Stock" (hereinafter, the "Series A
Preferred"), 1,818,182 shares of which are designated "Series B Preferred"
(hereinafter the "Series B Preferred") and 1,050,000 shares of which are
designated Series C Preferred. Immediately prior to the Closing, there will
be issued and outstanding 2,159,148 shares of Common Stock, 1,451,195 shares
of Series A Preferred 1,818,182 shares of Series B Preferred and no shares of
Series C Preferred. All issued and outstanding shares of Common Stock, Series
A Preferred and Series B Preferred have been duly authorized and validly
issued, and are fully paid and nonassessable. The Company has reserved
1,050,000 shares of Series C Preferred for issuance hereunder. The Company
has also reserved 1,451,195 shares of its Common Stock for issuance upon
conversion of the Series A Preferred, 1,818,182 shares of its Common Stock
for issuance upon

                                       2

<PAGE>

conversion of the Series B Preferred and 1,050,000 shares of Common Stock for
issuance upon conversion of the Series C Preferred. The Series C Preferred
shall have the rights, preferences, privileges and restrictions set forth in
the Articles. The Company has reserved 1,075,000 shares of Common Stock for
issuance pursuant to its 1996 Stock Option Plan, as amended. Except as set
forth above, there are no options, warrants or other rights to purchase any
of the Company's authorized and unissued capital stock. Except pursuant to
and set forth in this Agreement and the Voting Agreement, to the Company's
knowledge there are no voting trusts or agreements, shareholders' agreements,
pledge agreements, buy-sell agreements, rights of first refusal, preemptive
rights or proxies relating to any securities of the Company (whether or not
the Company is a party thereto). Except as set forth in the agreements named
on the Schedule of Exceptions, the Company has not granted any additional
rights, benefits or privileges to any holder of the Series A Preferred, the
Series B Preferred or to any of the Purchasers. All of the outstanding
securities of the Company were issued in compliance with the registration or
exemption provisions of all applicable federal and state securities laws. No
stock split, dividend, other recapitalization, or similar event or act has
been effected, declared, or voted since the Balance Sheet Date, as
hereinafter defined.

          3.5  AUTHORIZATION. All corporate action on the part of the
Company, its directors and shareholders necessary for the authorization,
execution, delivery and performance of this Agreement, the Registration
Rights Agreement, the Voting Agreement, the authorization, sale, issuance and
delivery of the Series C Preferred and the Conversion Stock, and the
performance of all of the Company's obligations hereunder and under the
Registration Rights Agreement and the Voting Agreement has been taken or will
be taken prior to the Closing. This Agreement, the Registration Rights
Agreement and the Voting Agreement when executed and delivered by the
Company, shall constitute valid and binding obligations of the Company,
enforceable in accordance with their terms, subject to laws of general
application relating to bankruptcy, insolvency and the relief of debtors and
rules of law governing specific performance, injunctive relief or other
equitable remedies. The Shares, when issued in compliance with the provisions
of this Agreement, will be validly issued, will be fully paid and
nonassessable; the Conversion Stock has been duly and validly reserved and,
when issued in compliance with the provisions of this Agreement and the
Articles, will be validly issued, fully paid and nonassessable; and the
Shares and the Conversion Stock will be free of any liens or encumbrances,
other than any liens or encumbrances created by or imposed upon the holders;
PROVIDED, however, that the Shares and the Conversion Stock may be subject to
restrictions on transfer under state and/or federal securities laws.

          3.6  FINANCIAL STATEMENTS. Attached to the Schedule of Exceptions
is a copy of the Company's unaudited balance sheet as at December 31, 1999
(the "Balance Sheet Date"), unaudited statement of cash flow for December 31,
1999 and unaudited income statement for December 31, 1999 (collectively, the
"Financial Statements"). The Financial Statements have been prepared in
accordance with generally accepted accounting principles consistently applied
throughout the periods indicated. The Financial Statements fairly present the
financial condition and operating results of the Company as of and for the
periods indicated. Except as set forth in the Financial Statements, as of the
date hereof the Company has no liabilities, contingent or otherwise, which
individually or in the aggregate would be material to the financial condition
or operating

                                       3

<PAGE>

results of the Company. Except as disclosed in the Financial Statements, the
Company is not a guarantor or indemnitor of any indebtedness of any other
person, firm or corporation.

          3.7  CHANGES. Since The Balance Sheet Date there has not been:

               (a) any change in the assets, liabilities, financial
condition or operating results of the Company from that reflected in the
Financial Statements, except changes in the ordinary course of business that
have not been, in the aggregate, materially adverse;

               (b) any damage, destruction or loss, whether or not covered
by insurance, materially and adversely affecting the assets, properties,
financial condition, operating results, prospects or business of the Company
(as such business is presently conducted);

               (c) any satisfaction or discharge of any lien, claim or
encumbrance or payment of any obligation by the Company, except in the
ordinary course of business and that is not material to the assets,
properties, financial condition, operating results or business of the Company
(as such business is presently conducted);

               (d) any change, except in the ordinary course of business
and that is not material to the assets, properties, financial condition,
operating results or business of the Company, in the contingent obligations
of the Company by way of guaranty or any assurance of performance or payment,
endorsement, indemnity, warranty, or otherwise;

               (e)  any waiver by the Company of a valuable right or of a
material debt owed to it;

               (f) any material change or amendment to a material contract
or arrangement by which the Company or any of its assets or properties is
bound or subject (including any agreement set forth on the Schedule of
Exceptions);

               (g)  any material change in any compensation arrangement or
agreement with any employee;

               (h)  any sale,  assignment  or transfer of any patents,
trademarks,  copyrights,  trade secrets or other intangible assets;

               (i)  any  resignation  or  termination  of employment of
any key officer of the Company;  and the Company does not know of the
impending resignation or termination of employment of any such officer;

               (j) receipt  of notice  that  there has been a loss of, or
 material  order  cancellation  by, any major customer of the Company;

                                     4

<PAGE>

               (k) any mortgage, pledge, transfer of a security interest in,
or lien, created by the Company, with respect to any of its material
properties or assets, except liens for taxes not yet due or payable;

               (l) any loans or guarantees made by the Company to or for the
benefit of its employees, officers or directors, or any members of their
immediate families, other than travel advances and other advances made in the
ordinary course of its business;

               (m) any declaration, setting aside or payment of any dividend
or other distribution in respect of any of the Company's capital stock, or
any direct or indirect redemption, purchase or other acquisition of any of
such stock by the Company;

               (n) any agreement or commitment by the Company to do any of
the things described in this Section 3.7; or

               (o) any other event or condition of any character that has
materially and adversely affected the business, prospects, condition,
affairs, operations, properties or assets of the Company.

          3.8  TITLE TO PROPERTIES AND ASSETS; LIENS, ETC. The Company has
good and marketable title to its properties (both real and personal) and
assets, and has good title to all its leasehold interests, in each case
subject to no mortgage, pledge, lien, lease, encumbrance or charge, other
than (i) the lien of current taxes not yet due and payable, and (ii) possible
minor liens and encumbrances which do not in any case materially detract from
the value of the property subject thereto or materially impair the operations
or the proposed operations of the Company, and which have not arisen
otherwise than in the ordinary course of business.

          3.9  TAXES. The Company has filed all tax returns, federal, state,
county and local, required to be filed by it, and the Company has paid all
taxes shown to be due by such returns as well as all other taxes, assessments
and governmental charges which have become due or payable, including without
limitation all taxes which the Company is obligated to withhold from amounts
owing to employees, creditors and third parties.

          3.10  COMPLIANCE WITH OTHER INSTRUMENTS, NONE BURDENSOME, ETC. The
Company is not in violation of any term of the Articles or its Bylaws, or in
violation in any material respect of any term or provision of any material
mortgage, indebtedness, indenture, contract, agreement, instrument, judgment
or decree (including any agreement set forth on the Schedule of Exceptions)
(hereinafter referred to collectively as "Contracts"), and is not in
violation of any order, statute, rule or regulation applicable to the Company
where such violation would materially and adversely affect the Company. The
execution, delivery and performance of and compliance with this Agreement,
the Registration Rights Agreement, the Voting Agreement and the issuance of
the Series C Preferred and the Conversion Stock, have not resulted and will
not result in any violation of, or conflict with, or constitute a default
under, the Articles, the Company's Bylaws or any Contract, nor result in the
creation of, any mortgage, pledge, lien, encumbrance or charge upon any of
the properties or assets of the Company.

                                       5

<PAGE>

          3.11  LITIGATION, ETC. There are no actions, suits, proceedings or
investigations pending against the Company or its properties before any court
or governmental agency nor, to the Company's knowledge, is there any basis
therefor or threat thereof. The Company is not in default with respect to any
order, writ, injunction or decree known to or served upon the Company of any
court or of any Federal, state, municipal or other governmental department,
commission, board, bureau, agency or instrumentality, domestic or foreign.
There is no action, suit, proceeding, or investigation by the Company pending
or threatened against others.

          3.12  INTELLECTUAL PROPERTY. To the Company's knowledge, the
Company owns or possesses adequate licenses or other sufficient rights to use
all patents, patent applications, trademarks, trademark applications, service
marks, service mark applications, trade names, copyrights, manufacturing
processes, formulae, trade secrets, customer lists and know how
(collectively, "Intellectual Property") necessary to the conduct of its
business as now conducted and as currently contemplated to be conducted. Set
forth on the Schedule of Exceptions is a list of all third party patents and
patent applications of which the Company is aware that may be relevant to the
Company's research. The Company has taken such precautions and measures as it
believes are reasonably necessary to protect the confidentiality and value of
its Intellectual Property. The Company has not received any communications
alleging that the Company has violated or, by conducting its business as
currently contemplated to be conducted, would violate any of the patents,
trademarks, service marks, trade names, copyrights or trade secrets or other
proprietary rights of any other person or entity.

          3.13  EMPLOYEES. To the Company's knowledge, no employee of the
Company is in violation of any term of any employment contract, patent
disclosure agreement or any other contract or agreement relating to the
relationship of such employee with the Company or any other party because of
the nature of the business conducted by the Company, nor is any employee of
the Company subject to any judgment, decree or order of any court or
administrative agency or subject with respect to any prior employer to any
non-contractual obligation, that would interfere with such employee's duties
to the Company or that would conflict with the Company's business as now
conducted. Each current or previous employee, officer and consultant of the
Company has executed agreements with the Company regarding confidentiality
and assignment of inventions, forms of which are attached hereto as EXHIBIT G
(each, an "Employee Proprietary Information and Invention Assignment
Agreement"). The Company does not believe it is or will be necessary to
utilize any inventions, trade secrets or proprietary information of any of
its employees made prior to their employment by the Company, except for
inventions, trade secrets or proprietary information that have been validly
assigned to the Company.

          3.14  REGISTRATION RIGHTS. Except as set forth in the Registration
Rights Agreement, the Company is not under any contractual obligation to
register (as defined in the Registration Rights Agreement) any of its
currently outstanding securities or any of its securities which may hereafter
be issued.

          3.15  GOVERNMENTAL CONSENT, ETC. No consent, approval or
authorization of or designation, declaration or filing with any governmental
authority or any private party on the part of

                                       6

<PAGE>

the Company is required in connection with the valid execution and delivery
of this Agreement, the Registration Rights Agreement, the Voting Agreement,
or the offer, sale or issuance of the Series C Preferred (and the Conversion
Stock), or the consummation of any other transaction contemplated hereby,
except (a) filing of the Articles in the office of the California Secretary
of State, (b) qualification (or taking such action as may be necessary to
secure an exemption from qualification, if available) of the offer and sale
of the Series C Preferred (and the Conversion Stock) under the California
Corporate Securities Law of 1968, as amended, and other applicable securities
laws, and (c) the consent of the parties to the Registration Rights Agreement
and the Voting Agreement to the amendment and restatement of such agreements.

          3.16  OFFERING. Subject to the accuracy of the Purchasers'
representations in Section 4 hereof, the offer, sale and issuance of the
Series C Preferred to be issued in conformity with the terms of this
Agreement, and the issuance of the Conversion Stock, constitute transactions
exempt from the registration requirements of Section 5 of the Securities Act
of 1933, as amended (the "Securities Act").

          3.17  MINUTE BOOKS. The minute books of the Company made available
to the Purchasers contain a complete summary of all meetings of directors and
shareholders since the date of incorporation and reflect all transactions
referred to in such minutes in all material respects.

          3.18  RELATED-PARTY TRANSACTIONS. Except as disclosed in the
Financial Statements, (a) no 5% or greater shareholder of the Company nor any
general partner thereof, (b) no employee, officer, or director of the Company
or any 5% or greater shareholder of the Company, and (c) no member of the
immediate family of any of the persons listed in (a) or (b) above, is
indebted to the Company, nor is the Company indebted (or committed to make
loans or extend or guarantee credit) to any of them. To the Company's
knowledge, none of such persons has any direct or indirect ownership interest
in any firm or corporation with which the Company is affiliated or with which
the Company has a business relationship, or any firm or corporation that
competes with the Company, except that employees, officer, or directors of
the Company and members of their immediate families may own stock in publicly
traded companies that may compete with the Company. No member of the
immediate family of any employee, officer or director of the Company, and no
member of the immediate family of any 5% or greater shareholder of the
Company nor any general partner, employee, officer or director thereof, is
directly or indirectly interested in any material contract with the Company.

          3.19  EMPLOYEE BENEFIT PLANS. The Company does not have any
Employee Benefit Plan as defined in the Employee Retirement Income Security
Act of 1974 or any employment contract, deferred compensation arrangement,
bonus plan, incentive plan, profit sharing plan, retirement agreement or
other employee compensation plan or agreement.

          3.20  REAL PROPERTY HOLDING CORPORATION. The Company is not a real
property holding corporation within the meaning of Internal Revenue Code
Section 897(c)(2) and any regulations promulgated thereunder.

                                       7

<PAGE>

          3.21  INSURANCE. The Company has fire and casualty and other
insurance policies with coverage customary for companies similarly situated
to the Company.

          3.22  LIABILITIES. The Company has no material liabilities and, to
the best of its knowledge, knows of no material contingent liabilities, not
disclosed in the Financial Statements, except current liabilities incurred in
the ordinary course of business subsequent to the Balance Sheet Date which
have not been, either in any individual case or in the aggregate, materially
adverse.

          3.23  FULL DISCLOSURE. This Agreement, the Schedule of Exceptions,
the Exhibits hereto, the Registration Rights Agreement and the Voting
Agreement do not contain any untrue statement of a material fact nor, to the
Company's knowledge, omit to state a material fact required to be stated or
necessary to make the statements, in light of the circumstances under which
such statements were made, not misleading. Notwithstanding the foregoing, any
projections provided to the Purchasers were prepared by the Company in a good
faith effort to describe the Company's business as now conducted and as
currently contemplated to be conducted, as well as the Company's products and
currently contemplated products and the markets therefor. The assumptions
underlying these projections were based upon reasonable investigation by the
Company as of the date thereof; however, there is no assurance that these
assumptions will prove to be valid or that the objectives reflected in such
projections will be achieved. There is no fact within the knowledge of the
Company (other than publicly known facts relating exclusively to political or
economic matters of general applicability that will adversely affect all
comparable entities) that may have the effect of preventing, delaying, making
illegal or otherwise interfering with any of the transactions contemplated
herein.

          3.24    AGREEMENTS; ACTION.

               (a) Except for agreements explicitly contemplated hereby,
agreements between the Company and its employees and consultants with respect
to the sale of the Company's Common Stock, there are no agreements,
understandings or proposed transactions between the Company and any of its
officers or directors or any affiliate thereof.

               (b) There are no agreements, understandings, instruments,
contracts, proposed transactions, judgments, orders, writs or decrees to
which the Company is a party or to its knowledge by which it is bound which
may involve (i) obligations (contingent or otherwise) of, or payments to, the
Company in excess of $50,000 (other than obligations of, or payments to, the
Company arising from purchase or sale agreements entered into in the ordinary
course of business), or (ii) the license of any patent, copyright, trade
secret or other proprietary right to or from the Company (other than licenses
arising from the purchase of "off the shelf" or other standard products), or
(iii) provisions restricting or affecting the development, manufacture or
distribution of the Company's products or services, or (iv) indemnification
by the Company with respect to infringements of proprietary rights (other
than indemnification obligations arising from purchase or sale agreements
entered into in the ordinary course of business).

               (c) The Company has not (i) declared or paid any dividends, or
authorized or made any distribution upon or with respect to any class or
series of its capital stock, (ii) incurred

                                       8

<PAGE>

any indebtedness for money borrowed or any other liabilities (other than with
respect to dividend obligations, distributions, indebtedness and other
obligations incurred in the ordinary course of business or as disclosed in
the Financial Statements) individually in excess of $50,000 or, in the case
of indebtedness and/or liabilities individually less than $50,000, in excess
of $100,000 in the aggregate, (iii) made any loans or advances to any person,
other than ordinary advances for travel expenses, or (iv) sold, exchanged or
otherwise disposed of any of its assets or rights, other than the sale of its
inventory in the ordinary course of business.

               (d) For the purposes of subsections (b) and (c) above, all
indebtedness, liabilities, agreements, understandings, instruments, contracts
and proposed transactions involving the same person or entity (including
persons or entities the Company has reason to believe are affiliated
therewith) shall be aggregated for the purpose of meeting the individual
minimum dollar amounts of such subsections.

          3.25  COMPLIANCE WITH LAWS; PERMITS. The Company is not in
violation of any applicable statute, rule, regulation, order or restriction
of any domestic or foreign government or any instrumentality or agency
thereof in respect of the conduct of its business as currently conducted or
as currently contemplated to be conducted, or the ownership of its
properties, which violation would materially and adversely affect the
business, assets, liabilities, financial condition, operations or prospects
of the Company. No governmental orders, permissions, consents, approvals or
authorizations are required to be obtained and no registrations or
declarations are required to be filed in connection with the execution and
delivery of this Agreement and the issuance of the Shares or the Conversion
Stock, except such as has been duly and validly obtained or filed, or with
respect to any filings that must be made after the Closing, as will be filed
in a timely manner. The Company has all franchises, permits, licenses and any
similar authority necessary for the conduct of its business as now being
conducted by it, the lack of which would materially and adversely affect the
business, properties, prospects or financial condition of the Company and
believes it can obtain, without undue burden or expense, any similar
authority for the conduct of its business as currently conducted.

          3.26  ENVIRONMENTAL AND SAFETY LAWS. To its knowledge, the Company
is not in violation of any applicable statute, law or regulation relating to
the environment or occupational health and safety, and to its knowledge, no
material expenditures are or will be required in order to comply with any
such existing statute, law or regulation.

          3.27  QUALIFIED SMALL BUSINESS. The Company represents and warrants
to the Purchasers that, to the best of its knowledge, the Series C Preferred
qualifies as "Qualified Small Business Stock" as defined in Section 1202(c)
of the Internal Revenue Code of 1986, as amended (the "Code") as of the date
hereof. The Company will comply with the reporting and record keeping
requirements of Section 1202 of the Code and any regulations promulgated
thereunder. The Company will use reasonable efforts to not repurchase any
stock of the Company if such repurchase would cause such Series C Preferred
not to so qualify as "Qualified Small Business Stock" provided, however, that
the Company shall not be obligated to take any action or refrain from taking
any action which the Company has determined, in good faith, is not in its
best business interests.

                                       9

<PAGE>

          3.28  INVESTMENT COMPANY ACT. The Company is not an "investment
company", or a company "controlled" by an "investment company", within the
meaning of the Investment Company Act of 1940, as amended.

          3.29  ANTI-ISRAELI BOYCOTT. The Company has not participated and is
not participating in, an anti-Israeli boycott within the scope of Chapter 7
of Part 2 of Division 4 of Title 2 of the California Government Code as in
effect from time to time.

          3.30  SBA REPRESENTATIONS. The Company, together with its
"Affiliates" (as that term is defined at Section 107.50 of Title 13 of the
Code of Federal Regulations), is a "Small Business" (as that term is defined
in Section 107.50 of Title 13 of the Code of Federal Regulations).

                                   SECTION  4.

                 REPRESENTATIONS AND WARRANTIES OF THE PURCHASERS

        Each Purchaser hereby severally represents and warrants to the Company
with respect to the purchase of the Shares as follows:

          4.1  INVESTMENT EXPERIENCE. Such Purchaser has substantial
experience in evaluating and investing in private placement transactions of
securities in companies similar to the Company so that such Purchaser is
capable of evaluating the merits and risks of its investment in the Company
and has the capacity to protect its own interests.

          4.2  ACCREDITED INVESTOR. Such Purchaser is either (i) an
"accredited investor" as that term is defined in Securities and Exchange
Commission Rule 501 of Regulation D, as presently in effect, or (ii) has a
preexisting personal or business relationship with the Company or any of its
officers, directors or controlling persons, or by reason of such Purchaser's
business or financial experience or the business or financial experience of
such Purchaser's professional advisors who are unaffiliated with and who are
not compensated by the Company or any affiliate or selling agent of the
Company, directly or indirectly, has the capacity to protect such Purchaser's
own interests in connection with the purchase of the Series C Preferred.

          4.3  INVESTMENT. Such Purchaser is acquiring the Series C Preferred
and the underlying Common Stock for investment for its own account, not as a
nominee or agent, and not with the view to, or for resale in connection with,
any distribution thereof. Such Purchaser understands that the Series C
referred to be purchased and the underlying Common Stock have not been, and
will not be, registered under the Securities Act by reason of a specific
exemption from the registration provisions of the Securities Act, the
availability of which depends upon, among other things, the bona fide nature
of the investment intent and the accuracy of such Purchaser's representations
as expressed herein.

          4.4  RULE 144. Such Purchaser acknowledges that the Series C
Preferred and the Conversion Stock must be held indefinitely unless
subsequently registered under the Securities Act or unless an exemption from
such registration is available. Such Purchaser is aware of the

                                      10
<PAGE>

provisions of Rule 144 promulgated under the Securities Act which permit
limited resale of shares purchased in a private placement subject to the
satisfaction of certain conditions, including, among other things, the
existence of a public market for the shares, the availability of certain
current public information about the Company, the resale occurring not less
than one year after a party has purchased and paid for the security to be
sold, the sale being effected through a "broker's transaction" or in
transactions directly with a "market maker" and the number of shares being
sold during any three month period not exceeding specified limitations.

          4.5  NO PUBLIC MARKET. Such Purchaser understands that no public
market now exists for any of the securities issued by the Company and that
the Company has made no assurances that a public market will ever exist for
the Company's securities.

          4.6  ACCESS TO DATA. Such Purchaser has had an opportunity to
discuss the Company's business, management and financial affairs with its
management. Such Purchaser also has had an opportunity to ask questions of
officers of the Company, which questions were answered to its satisfaction.
Such Purchaser understands that such discussions, as well as any written
information issued by the Company, were intended to describe certain aspects
of the Company's business and prospects but were not a thorough or exhaustive
description; provided, that this representation shall not be deemed to limit
the representations of the Company under Section 3. Such Purchaser's decision
to enter into the transactions contemplated hereby is based on its own
evaluation of the risks and merits of the purchase and the Company's proposed
business activities.

          4.7  AUTHORIZATION. This Agreement, the Registration Rights
Agreement and the Voting Agreement, when executed and delivered by such
Purchaser, will each constitute a valid and legally binding obligation of the
Purchaser, enforceable in accordance with its terms, subject to laws of
general application relating to bankruptcy, insolvency and the relief of
debtors and rules of law governing specific performance, injunctive relief or
other equitable remedies.

          4.8  TAX LIABILITY. Such Purchaser has reviewed with its own tax
advisors the federal, state, local and foreign tax consequences of this
investment and the transactions contemplated by this Agreement. With respect
to such tax consequences, such Purchaser relies solely on such advisors and
not on any statements or representations of the Company or any of its agents.
Such Purchaser understands and agrees that it (and not the Company) shall be
responsible for any of its own tax liability that may arise as a result of
this investment or the transactions contemplated by this Agreement.

                                SECTION 5

                   CONDITIONS TO CLOSING OF PURCHASERS

        The Purchasers' obligations to purchase the Shares at the Closing
are, at the option of the Purchasers, subject to the fulfillment of the
following conditions:

                                      11

<PAGE>

          5.1  REPRESENTATIONS AND WARRANTIES. The representations and
warranties made by the Company in Section 3 hereof, as qualified by EXHIBIT
C, shall have been true and correct when made and shall be true and correct
as of the Closing Date.

          5.2  COVENANTS. All covenants, agreements and conditions contained
in this Agreement to be performed by the Company on or prior to the Closing
Date shall have been performed or complied with in all material respects.

          5.3  NO INJUNCTION, ORDER, ETC. No preliminary or permanent
injunction or other binding order, decree or ruling issued by a court or
governmental agency shall be in effect which shall have the effect of
preventing the consummation of the transactions contemplated by this
Agreement.

          5.4  OPINION OF COMPANY'S COUNSEL. The Purchasers shall have
received from Wilson Sonsini Goodrich & Rosati, counsel to the Company, an
opinion addressed to them, dated the Closing Date, in substantially the form
of EXHIBIT G.

          5.5  COMPLIANCE CERTIFICATE. The Company shall have delivered to
the Purchasers a certificate of the Company, executed by the Chairman of the
Board of the Company, dated the Closing Date, and certifying, among other
things, to the fulfillment of the conditions specified in Sections 5.1 and
5.2 of this Agreement.

          5.6  REGISTRATION RIGHTS AGREEMENT. Each contemplated party thereto
shall have executed and delivered the Registration Rights Agreement in
substantially the form attached hereto as EXHIBIT D.

          5.7  BLUE SKY. The Company shall have obtained all necessary Blue
Sky law permits and qualifications, or have the availability of exemptions
therefrom, required by any state for the offer and sale of the Series C
Preferred and the Conversion Stock.

          5.8  ARTICLES. The Articles shall have been filed with the
California Secretary of State.

          5.9  LEGAL MATTERS. All material matters of a legal nature which
pertain to this Agreement and the transactions contemplated hereby shall have
been reasonably approved by counsel to the Purchasers.

          5.10  SUPPORTING DOCUMENTS. The Purchasers or their counsel shall
have received copies of the following documents:

                (a) (i) the Articles, certified as of a recent date by the
Secretary of State of the State of California, and (ii) a certificate of said
Secretary dated as of a recent date as to the due incorporation and good
standing of the Company and a certificate of the California Franchise Tax
Board as to the payment of taxes by the Company;

                                       12

<PAGE>

                (b) a certificate of the Secretary or an Assistant Secretary
of the Company dated the Closing Date and certifying: (i) that attached
thereto is a true and complete copy of the Bylaws of the Company as in effect
on the date of such certification; (ii) that attached thereto is a true and
complete copy of all resolutions adopted by the Board of Directors or the
shareholders of the Company authorizing the execution, delivery and
performance of this Agreement, the Registration Rights Agreement, the Voting
Agreement, the issuance, sale and delivery of the Series C Preferred Stock
and the reservation of the Conversion Stock, and that all such resolutions
are in full force and effect and are all the resolutions adopted in
connection with the transactions contemplated by this Agreement, the
Registration Rights Agreement and the Voting Agreement; and (iii) that the
Articles have not been amended since the date of the last amendment referred
to in the certificate delivered pursuant to clause (a)(ii) above.

          5.11  EMPLOYEE PROPRIETARY INFORMATION AGREEMENTS. The Company and
all Company officers, consultants and employees shall have executed and
delivered an Employee Proprietary Information and Invention Assignment
Agreement in the form attached hereto as EXHIBIT F.

          5.12  PURCHASE AND DELIVERY OF SHARES. Purchasers of an aggregate
of at least $10,000,000 of Series C Preferred shall have paid the purchase
price therefor to the Company and the Company shall have delivered to each
such Purchaser at the Closing a stock certificate(s) representing the number
of the Shares to be acquired by such Purchaser, as designated in EXHIBIT A.

          5.13  VOTING AGREEMENT. Each party thereto and the Company shall
have executed the Voting Agreement in the form attached as EXHIBIT E.

          5.14  SMALL BUSINESS CONCERN DOCUMENTS. The Company shall have
executed and delivered to each Purchaser who requests them, a Size Status
Declaration on SBA Form 480 and an Assurance of Compliance on SBA Form 652,
and shall provided to each Purchaser who so requests information necessary
for the preparation of a Portfolio Financing Report on SBA Form 1031. Any
information provided by the Company to any Purchaser pursuant to this Section
5.15 shall be accurate and complete.

                                SECTION 6

                     CONDITIONS TO CLOSING OF COMPANY

          The Company's obligation to sell and issue the Shares at the
Closing Date is, at the option of the Company, subject to the fulfillment as
of the Closing Date of the following conditions:

          6.1  REPRESENTATIONS AND WARRANTIES. The representations and
warranties made by the Purchasers in Section 4 hereof shall be true and
correct when made and shall be true and correct on the Closing Date.

                                      13

<PAGE>

          6.2  BLUE SKY COMPLIANCE. The Company shall have obtained all
necessary Blue Sky law permits and qualifications, or have the availability
of exemptions therefrom, required by any state for the offer and sale of the
Series C Preferred and the Conversion Stock.

          6.3  ARTICLES. The Articles shall have been filed with the
California Secretary of State and shall be in full force and effect on the
Closing Date.

          6.4  REGISTRATION RIGHTS AGREEMENT. Each contemplated party thereto
shall have executed and delivered the Registration Rights Agreement in
substantially the form attached hereto as EXHIBIT D.

          6.5  LEGAL MATTERS. All material matters of a legal nature which
pertain to this Agreement, and the transactions contemplated hereby, shall
have been reasonably approved by counsel to the Company.

          6.6  COVENANTS. All covenants, agreements, and conditions contained
in this Agreement to be performed by the Purchasers on or prior to the
Closing Date shall have been performed or complied with in all material
respects.

          6.7  VOTING AGREEMENT. Each party thereto shall have executed the
Voting Agreement in the form attached as EXHIBIT E.

                                 SECTION 7

                          COVENANTS OF THE COMPANY

          The Company hereby covenants and agrees as follows:

          7.1  ANNUAL, QUARTERLY AND MONTHLY FINANCIAL INFORMATION. So long
as a Purchaser holds at least 50,000 shares of Series C Preferred or
Conversion Stock or a combination of both (as adjusted for stock splits,
stock dividends and the like), the Company shall deliver to such Purchaser
(i) as soon as practicable after the end of each fiscal year of the Company,
and in any event within 90 days thereafter, annual financial statements
(balance sheet, income statement and statement of cash flows) that have been
audited by a nationally recognized firm; (ii) as soon as practicable after
the end of the first, second and third quarterly accounting periods in each
fiscal year of the Company, and in any event within 21 days thereafter,
unaudited quarterly financial statements (balance sheet, income statement and
statement of cash flows) prepared in accordance with generally accepted
accounting principles consistently applied; and (iii) upon the request of any
such Purchaser, as soon as practicable after the end of each month, unaudited
monthly financial statements (balance sheet, income statement and cash
flows), and upon the request of any Purchaser that holds at least 100,000
shares of Series C Preferred or Conversion Stock or a combination of both (as
adjusted for stock splits, stock dividends and the like), a reconciliation
comparing such monthly statements to the operating plan.

                                      14

<PAGE>

          7.2  ADDITIONAL INFORMATION RIGHTS. So long as a Purchaser holds at
least 100,000 shares of Series C Preferred or Conversion Stock or a
combination of both (as adjusted for stock splits, stock dividends and the
like), the Company will (i) furnish such Purchaser with a copy of the
Company's annual operating plan within thirty (30) days prior to the
beginning of the Company's fiscal year, and (ii) permit such Purchaser and
its representatives to visit and inspect the Company's properties and to
examine its books of account and to discuss the Company's affairs, finances
and accounts with its officers and other Company designated representatives,
all at such reasonable times as may be requested by such Purchaser on five
days prior notice; PROVIDED, HOWEVER, that the Company will not be obligated
pursuant to this Section 7.2 to provide any information on its technology
which it reasonably considers to be a trade secret or similar confidential
information.

          7.3  TERMINATION OF ADDITIONAL INFORMATION RIGHTS. The Company's
obligations under Section 7.1 and Section 7.2 shall terminate and be of no
further force or effect upon a Qualified IPO (as such term is defined in the
Company's Articles.)

          7.4  EMPLOYEE PROPRIETARY INFORMATION AGREEMENTS. The Company shall
obtain, and shall cause its subsidiaries to obtain, an Employee Proprietary
Information and Invention Assignment Agreement in substantially the form of
EXHIBIT F from all future officers, key employees, other employees and
consultants who will have access to confidential information of the Company
or any of its subsidiaries, upon their employment by the Company or any of
its subsidiaries.

          7.5  KEY PERSON LIFE INSURANCE. The Company will use its best
efforts to obtain and maintain term life insurance under a policy or policies
issued by insurers of recognized standing in the aggregate amount of
$1,000,000.00 on the lives of each of Daniel V. Santi and Chaitan Khosla with
the Company named as sole beneficiary of such insurance. Such policy or
policies will remain in force for so long as the Board of Directors shall
determine.

          7.6  RESERVATION OF ADDITIONAL SHARES FOR ISSUANCE UNDER 1996 STOCK
PLAN. Until the earlier of (i) six (6) months after the Closing or (ii) the
effective date of the Company's initial public offering, the Company will not
grant options covering more than 150,000 shares in addition to those
currently authorized under the Company's 1996 Stock Plan without first
obtaining the consent of the holders of at least fifty percent (50%) of the
Series C Preferred.

                                SECTION 8

                           RIGHT OF FIRST OFFER

          For so long as a Purchaser holds at least 180,000 shares of Common
Stock and/or Common Stock equivalents (including, for purposes of this
Section 8, shares of Common Stock issued or issuable upon the conversion of
shares of Series C Preferred, subject to proportional adjustment to reflect
stock splits, stock dividends and the like), such Purchaser(s)
("Investor(s)")will be entitled to the following right of first offer:

                                      15

<PAGE>

          8.1  OFFER OF SECURITIES. Except in the case of Excluded Securities
(as hereafter defined), the Company shall not issue, sell or exchange, agree
to issue, sell or exchange, or reserve or set aside for issuance, sale or
exchange, any (i) shares of Common Stock, (ii) any other equity security of
the Company, (iii) any debt security of the Company that is a combination of
debt and equity, (iv) any debt security of the Company that by its terms is
convertible into or exchangeable for any equity security of the Company, or
(v) any option, warrant or other right to subscribe for, purchase or
otherwise acquire any equity security or any such debt security of the
Company, unless in each case the Company shall have first offered to sell to
such Investor(s) such securities (the "Offered Securities"), at a price and
on such other terms as shall have been specified by the Company in writing
delivered to the Investor(s) (the "Offer"), which offer by its terms shall
remain open for a period of twenty (20) days from the date it is delivered by
the Company to such Investor(s).

          8.2  NOTICE OF ACCEPTANCE. Such Investor(s) shall each have the
right to purchase up to that portion of the Offered Securities which is equal
to the product obtained by multiplying the number of Offered Securities by a
fraction, the numerator of which shall be the number of shares of the Common
Stock of the Company (assuming full conversion of all issued and outstanding
convertible securities) then owned by such Investor and the denominator of
which shall be the total number of shares of the Common Stock of the Company
(assuming full conversion of all issued and outstanding Preferred Stock) then
issued and outstanding. Notice of an Investor's intention to accept an Offer
shall be evidenced in writing by such Investor and delivered to the Company
prior to the end of the 20-day period of such Offer, and shall set forth such
portion of the Offered Securities as such Investor elects to purchase (the
"Notice of Acceptance").

          8.3  OTHER PURCHASERS; CLOSING. The Company shall have 120 days
from the expiration of the foregoing 20-day period to sell all or any part of
such Offered Securities as to which a Notice of Acceptance has not been given
by the Investor(s) (the "Refused Securities") to any other person or persons,
but only upon terms and conditions, including, without limitation, unit price
and interest rates, which are no more favorable, in the aggregate, to such
other person or persons or less favorable to the Company than those set forth
in the Offer. Upon the closing of the sale to such other person or persons of
all the Refused Securities, which shall include payment of the purchase price
to the Company in accordance with the terms of the Offer, the Investor(s)
shall purchase from the Company, and the Company shall sell to the
Investor(s), the Offered Securities, if any, in respect of which a Notice of
Acceptance was delivered to the Company by the Investor(s) upon the terms
specified in the Offer. The purchase by the Investor(s) of any Offered
Securities is subject in all cases to the preparation, execution and delivery
by the Company and the Investor of a purchase agreement relating to such
Offered Securities on substantially the same terms as the Refused Securities
are sold to such other person or persons. In each case, any Offered
Securities not purchased by the Investor(s) or other person or persons in
accordance with this Section 8.3 may not be sold or otherwise disposed of
until they are again offered to the Investor(s) under the procedures
specified in this Section 8.

          8.4  EXCLUDED SECURITIES. The rights of the Investor(s) under this
Section 8 shall not apply to the following securities (the "Excluded
Securities"):

                                      16

<PAGE>

               (i) Shares of Common Stock issuable or issued to employees,
officers, directors or consultants of the Company directly or pursuant to a
stock option plan or stock purchase plan or any stock option grant, stock
purchase agreement or other agreement, in each case approved by at least
sixty-five percent (65%) of the members of the Board of Directors of the
Company;

               (ii) Common Stock issued as a stock dividend or upon any stock
split or other subdivision or combination of shares of Common Stock;

               (iii) Common Stock issued upon conversion of any shares of
Preferred Stock;

               (iv) any  securities  issued for  consideration  (other than
cash)  pursuant to a merger,  consolidation, acquisition or similar business
combination; and

               (v) Common Stock issued upon conversion of any other shares of
convertible securities of the Company, provided that the right of first offer
established by this Section 8 applied with respect to the initial sale or
grant by the Company of such securities.

          8.5  NON-ASSIGNMENT. Notwithstanding the provisions of Section 9.3
hereof, the rights under this Section 8 shall not be assignable except to an
Affiliate of the Investor. For purposes of this Section 8.5, "Affiliate"
shall mean any person controlling, controlled by or under common control with
another person. "Control" shall mean the right to direct the management or
policies of the person or to elect or appoint a majority of its managerial
body (such as the board of directors of a corporation, the managers of a
limited liability company, the general partners of a partnership, the
trustees of a trust, etc.), or the ownership of more than 50% of the equity
interests of the person. "Person" shall mean any individual, corporation,
company, partnership, trust, association or other legal entity.

          8.6  TERMINATION OF RIGHT. Notwithstanding the foregoing provisions
of this Section 8, the rights of the Investors and the obligations of the
Company under this Section 8 shall be inapplicable to securities offered
pursuant to a Qualified IPO and the provisions of this Section 8 shall
terminate upon (i) the consummation of a Qualified IPO (as such term is
defined in the Articles), and (ii) a consolidation or merger of the Company
with or into any other entity or entities, the acquisition of the Company by
any other entity or entities, or the sale of all or substantially all of the
assets or voting control of the Company in which the prior shareholders of
the Company do not own at least a majority of the outstanding shares of the
surviving entity.

                              SECTION 9

                            MISCELLANEOUS

          9.1  GOVERNING LAW. This Agreement shall be governed and construed
in all respects in accordance with the laws of the State of California as
applied to agreements made and performed in California by residents of the
State of California.

                                      17

<PAGE>

          9.2  SURVIVAL. The representations, warranties, covenants and
agreements made herein shall survive any investigation made by any Purchaser
and the closing of the transactions contemplated hereby.

          9.3  SUCCESSORS AND ASSIGNS. Except as otherwise provided herein,
the provisions hereof shall inure to the benefit of, and be binding upon, the
successors, assigns, heirs, executors and administrators of the parties
hereto; PROVIDED, HOWEVER, that the rights of a Purchaser to purchase the
Series C Preferred shall not be assignable except as set forth in Section 8.5.

          9.4  ENTIRE AGREEMENT; AMENDMENT. This Agreement and the other
documents delivered pursuant hereto at the Closing constitute the full and
entire understanding and agreement between the parties with regard to the
subjects hereof and thereof, and no party shall be liable or bound to any
other party in any manner by any warranties, representations or covenants
except as specifically set forth herein or therein. Except as expressly
provided herein, neither this Agreement nor any term hereof may be amended,
waived, discharged or terminated other than by a written instrument signed by
the party against whom enforcement of any such amendment, waiver, discharge
or termination is sought; PROVIDED, HOWEVER, that holders of at least seventy
percent (70%) of the Conversion Stock may, with the Company's written consent
(which consent may be evidenced by execution of an amendment, waiver or other
modification), waive, modify or amend on behalf of all holders, any
provisions hereof. Each Purchaser acknowledges that by the operation of this
Section 9.4 the holders of seventy percent (70%) of the Conversion Stock may
have the right and power to diminish or eliminate all rights of such
Purchaser under this Agreement.

          9.5  NOTICES, ETC. All notices and other communications required or
permitted hereunder shall be in writing and shall be, (i) if to a domestic
address, mailed by registered or certified mail, postage prepaid, or (ii) if
to an overseas address, by international air courier or other comparable
international air express service specifying not more than three days'
delivery, or in any case if otherwise delivered by hand or by messenger,
addressed (a) if to a Purchaser, at such Purchaser's address set forth in
Exhibit A, or at such other address as such Purchaser shall have furnished to
the Company in writing, or (b) if to any other holder of any Shares, at such
address as such holder shall have furnished the Company in writing, or, until
any such holder so furnishes an address to the Company, then to and at the
address of the last holder of such Shares who has so furnished an address to
the Company, or (c) if to the Company, one copy should be sent to its address
set forth above and addressed to the attention of the Corporate Secretary, or
at such other address as the Company shall have furnished to the Purchasers.
Each such notice or other communication shall for all purposes of this
Agreement be treated as effective or having been given when delivered if
delivered personally, or, if sent by mail, at the earlier of its receipt or
five days after the same has been deposited in a regularly maintained
receptacle for the deposit of the United States mail, addressed and mailed as
aforesaid, or if sent by international air courier or air express service,
three business days after shipment by the sender.

          9.6  CALIFORNIA CORPORATE SECURITIES LAW. THE SALE OF THE
SECURITIES WHICH ARE THE SUBJECT OF THIS AGREEMENT HAS NOT BEEN QUALIFIED
WITH THE COMMISSIONER OF CORPORATIONS OF THE STATE OF CALIFORNIA AND THE

                                      18

<PAGE>

ISSUANCE OF SUCH SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE
CONSIDERATION THEREFOR PRIOR TO SUCH QUALIFICATION IS UNLAWFUL UNLESS THE
SALE OF SECURITIES IS EXEMPT FROM THE QUALIFICATION BY SECTION 25100, 25102,
OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO
THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON SUCH QUALIFICATION BEING
OBTAINED, UNLESS THE SALE IS SO EXEMPT.

          9.7  EXPENSES. The Company and each Purchaser shall bear its own
expenses incurred on its behalf with respect to this Agreement and the
transactions contemplated hereby, except that at the Closing the Company
shall pay the reasonable fees and expenses of Testa, Hurwitz & Thibeault,
LLP, as special counsel to the Purchasers, in an amount not to exceed $20,000
and will also reimburse AP Asset Management for up to $20,000 in costs of
intellectual property and other due diligence review.

          9.8  SEVERABILITY. In the event that any provision of this
Agreement becomes or is declared by a court of competent jurisdiction to be
illegal, unenforceable or void, this Agreement shall continue in full force
and effect without such provision; PROVIDED, HOWEVER, that no such
severability shall be effective if it materially changes the economic benefit
of this Agreement to any party.

          9.9  TITLES AND SUBTITLES. The titles and subtitles used in this
Agreement are used for convenience only and are not considered in construing
or interpreting this Agreement.

          9.10  COUNTERPARTS. This Agreement may be executed in any number of
counterparts, each of which may be executed by less than all of the
Purchasers, each of which shall be enforceable against the parties actually
executing such counterparts, and all of which together shall constitute one
instrument.

          9.11  BROKER'S FEES. Each party hereto represents and warrants that
no agent, broker, investment banker, person or firm acting on behalf of or
under the authority of such party hereto is or will be entitled to any
broker's or finder's fee or any other commission directly or indirectly in
connection with the transactions contemplated herein. Each party hereto
further agrees to indemnify each other party for any claims, losses or
expenses incurred by such other party as a result of the representation of
this Section 9.11 being untrue.

          9.12  EXCULPATION AMONG PURCHASERS. Each Purchaser acknowledges
that it is not relying upon any person, firm, or corporation, other than the
Company and its officers and directors, in making its investment or decision
to invest in the Company. Each Purchaser agrees that no Purchaser nor the
respective controlling persons, officers, directors, partners, agents, or
employees of any Purchaser shall be liable for any action heretofore or
hereafter taken or omitted to be taken by any of them in connection with the
Shares and Conversion Stock.

                  [Remainder of Page Intentionally Left Blank]

                                      19

<PAGE>

          IN WITNESS WHEREOF, the parties have executed this Series C
Preferred Stock Purchase Agreement as of the date first above written.

"COMPANY"                              KOSAN BIOSCIENCES INCORPORATED

                                       By:
                                           -------------------------------
                                       Title:
                                              ----------------------------

           (Signature Page to Series C Stock Purchase Agreement)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00012-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00012-of-00352.parquet"}]]